Resolute Progress Down a Long and Winding Road Leads to the Promised Land of Prostate-Specific Membrane Antigen–Based Therapies for Prostate Cancer

Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591. November 03, 2023 ARTICLE CITATION DOI: 10.1200/JCO.23.02310 Journal of Clinical Oncology - published online before print January 5, 2024 PMID: 38181307 Resolute Progress Down a Long and Winding Road Leads to the Promised Land of Prostate-Specific Membrane Antigen–Based Therapies for Prostate Cancer Samuel R. Denmeade , MD1xSamuel R. DenmeadeSearch for articles by this author Show More 1Johns Hopkins University School of Medicine, Baltimore, MD https://doi.org/10.1200/JCO.23.02310 First Page Full Text PDF Figures and Tables © 2024 by American Society of Clinical Oncology Companion Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591